Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2016 · 10-Q
Revenue$1.33M$1.33M+47.8% vs Q1 2015 Net Income-$5.34M-$5.34MN/M vs Q1 2015 EPS Diluted-$0.41-$0.41N/M vs Q1 2015 Gross Profit$766,000+151.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flow-$5,058,000N/M Free Cash Flowderived-$5,127,000N/M Margins · derivedGross margin57.5%+23.7 pt vs Q1 2015
Operating margin-382.4%+1945.5 pt vs Q1 2015
Net margin-400.5%+2033.7 pt vs Q1 2015
ended Mar 31, 2016 · filed May 10, 2016 · 40 d after period end